infection prophylaxis and management
Sponsors
Fred Hutchinson Cancer Center, European Organisation for Research and Treatment of Cancer - EORTC, University Hospital Birmingham, City of Hope Medical Center, Roswell Park Cancer Institute
Conditions
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
Phase 2
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
CompletedNCT00002673
Start: 1995-06-30End: 2002-02-28Target: 30Updated: 2010-06-17
T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant
NCT00986557
Start: 2009-09-30Target: 78Updated: 2013-08-26
Phase 3
Unknown Phase
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active, not recruitingNCT01199562
Start: 2010-12-01End: 2026-12-01Updated: 2026-01-28
Bathing Bundle Regimen in Reducing Gynecological Surgical Site Infection in Patients Undergoing Surgery
CompletedNCT01597804
Start: 2011-04-30End: 2016-04-30Updated: 2020-07-23